We introduce classes of differential susceptibility and infectivity epidemic models. These models address the problem of flows between the different susceptible, infectious and infected compartments and differential death rates as well. We prove the global stability of the disease free equilibrium when the basic reproduction ratio R 0 ≤ 1 and the existence and uniqueness of an endemic equilibrium when R 0 > 1. We also prove the global asymptotic stability of the endemic equilibrium for a differential susceptibility and staged progression infectivity model, when R 0 > 1. Our results encompass and generalize those of Hyman and Li (J Math Biol 50:626-644, 2005; Math Biosci Eng 3:89-100, 2006).
Introduction
The primary objective of this paper is to give results on global stability for epidemiological models with differentiation in susceptibility for infection and differentiation in infectivity. The first models with differential infectivity has been introduced for studying HIV infection (Jacquez et al. 1991 (Jacquez et al. , 1988 Simon and Jacquez 1992) by Jacquez et al. circa 1990s. The term differential infectivity has been coined by Hyman and Li (2005a,b) and Hyman et al. (1999 Hyman et al. ( , 2001 . Models with differential susceptibility has been introduced in the references Hyman and Li (2005a, 2006) .
The rationale to introduce differential infectivity and susceptibility is motivated by the heterogeneity, concerning the mode of infection, for the individuals.
For many reasons difference in susceptibility to infection can occur : genetic variations, different social behaviors, different states of immunization, different vaccines … The infection by HBV, hepatitis B, is typically a disease where simultaneously differential susceptibility and infectivity appear:
Hepatitis B virus (HBV) is a bloodborne and sexually transmitted virus. The liver is the primary site of HBV replication. After a susceptible person is exposed, the virus enters the liver via the bloodstream. Hepatitis B is one of the major diseases of mankind and is a serious global public health problem. Of the 2 billion people who have been infected with the hepatitis B virus (HBV), more than 350 million have chronic (lifelong) infections. Rates of new infection and acute disease are highest among adults, but chronic infection is more likely to occur in persons infected as infants or young children. These chronically infected persons are at high risk of death from cirrhosis of the liver and liver cancer, diseases that kill about one million persons each year. According to CDC and WHO, risk for chronic infection is inversely related to age at infection: approximately 90% of infected infants and 30% of infected children aged under 5 years become chronically infected, compared with 5% of adults. This difference in the evolution of infection introduces naturally differential susceptibility.
Indeed hepatitis B is a major public health problem in developing countries of Africa and Asia (where prevalence is greater than 8%). In much of the developing world, (subSaharan Africa, most of Asia, and the Pacific), most people become infected with HBV during childhood, and 8-10% of people in the general population become chronically infected. In these regions liver cancer caused by HBV figures among the first three causes death by cancer in men.
Asymptomatic carriers play an important role in the transmission of HBV. Usually asymptomatic carriers are considered as less infectious than acute carriers, which is a reason for incorporating differential susceptibility. Vaccination is recognized as the most efficient way of preventing hepatitis B. But the problem of imperfect vaccine introduce naturally differential susceptibility. Even if HBV vaccine is very efficient it does not offer 100% protection against infection. According WHO, Hepatitis B vaccine is 95% effective in preventing HBV infection and its chronic consequences, Then vaccinated individuals form a class of individual with different susceptibility.
In Anderson and May (1991) , May and Anderson consider a model of HBV infection. They distinguishes, in this model the susceptible individuals according to their response. They assume that a proportion of births to infected carriers are themselves
